Controversial Boston Biolab Gets Federal Approval
In a notice published Wednesday in the Federal Register, the National Institutes of Health said that after “careful consideration” it has concluded that BU’s National Emerging Infectious Diseases Laboratories in the city’s South End, which will perform research on some of the world’s deadliest germs, “poses minimal risk to the community.”
The decision clears the way for final state environmental review, which has been in limbo pending the federal decision.
The 192,000 square foot lab still faces legal challenges.
A lawyer for neighbors suing to block the lab tells The Boston Globe there are still “gaps in the assessment.”